VICTORIA BLAIR: Open Payments
NPI 1629128483 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 41 payments from 14 companies in 2025. Trend: 2023 $525 · 2024 $778 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $190 |
| Corcept Therapeutics | 7 | $161 |
| Amgen Inc. | 4 | $158 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
| PFIZER INC. | 1 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Novo Nordisk Inc | 2 | $30 |
| Lilly USA, LLC | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
Products named: Korlym, REPATHA, VRAYLAR, QULIPTA, FANAPT, CAPLYTA, Wegovy, JARDIANCE.
Industry payments across ID — which companies pay providers there.
